Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1185 of 1,261
  1. US 6524583

    Antibody methods for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System Β· Granted Feb 25, 2003 Β· Expires Feb 20, 2023

    expired
  2. US 6525062

    Method of treating pain using nalbuphine and opioid antagonists

    The Regents of the University of California Β· Granted Feb 25, 2003 Β· Expires Feb 20, 2023

    expired
  3. US 6524613

    Hepatocellular chimeraplasty

    Regents of the University of Minnesota Β· Granted Feb 25, 2003 Β· Expires Feb 20, 2023

    expired
  4. US 6524840

    Human endothelin converting enzyme-like proteins and polynucleotides encoding the same

    Lexicon Genetics, Inc. Β· Granted Feb 25, 2003 Β· Expires Feb 20, 2023

    expired
  5. US 6525242

    Propagation of human hepatocytes in non-human mammals

    UNIVERSITY OF CONNECTICUT Β· Granted Feb 25, 2003 Β· Expires Feb 20, 2023

    expired
  6. US 6524590

    Identification of a new ehrlichia species from a patient suffering from ehrlichiosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Feb 25, 2003 Β· Expires Feb 20, 2023

    expired
  7. US 6524568

    Enriched platelet wound healant

    Cytomedix, Inc. Β· Granted Feb 25, 2003 Β· Expires Feb 20, 2023

    expired
  8. US 6521212

    Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation

    United Therapeutics Corporation Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  9. US 6521257

    Gelled compositions

    Ohkura Pharmaceutical Co., Ltd. Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  10. US 6521615

    Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying intracellular pyrophosphate content in peripheral blood cells

    The Regents of the University of California Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  11. US 6521635

    Inhibition of MXR transport by acridine derivatives

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  12. US 6521659

    Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor

    The Institute for Pharmaceutical Discovery, LLC Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  13. US 6521256

    Stabilized pharmaceutical composition

    Takeda Chemical Industries Ltd. Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  14. US 6521229

    41 kDa Cryptosporidium parvum oocyst wall protein

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  15. US 6521633

    Treating NIDDM with RXR agonists

    Ligand Pharmaceuticals Incorporated Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  16. US 6521417

    Engineered protein kinases which can utilize modified nucleotide triphosphate substrates

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  17. US 6521657

    Thio-oxindole derivatives

    Ligand Pharmaceuticals Incorporated Β· Granted Feb 18, 2003 Β· Expires Feb 13, 2023

    expired
  18. US 6517842

    Marburg virus vaccines

    The United States of America as represented by the Secretary of the Army Β· Granted Feb 11, 2003 Β· Expires Feb 6, 2023

    expired
  19. US 6518291

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated Β· Granted Feb 11, 2003 Β· Expires Feb 6, 2023

    expired
  20. US 6518243

    Desleucyl glycopeptide antibiotics and methods of making same

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Feb 11, 2003 Β· Expires Feb 6, 2023

    expired
  21. US 6518242

    Derivatives of glycopeptide antibacterial agents

    Theravance, Inc. Β· Granted Feb 11, 2003 Β· Expires Feb 6, 2023

    expired
  22. US 6518061

    IL-13 receptor specific chimeric proteins and uses thereof

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Feb 11, 2003 Β· Expires Feb 6, 2023

    expired
  23. US 6517828

    C-CAM as an angiogenesis inhibitor

    The Board of Regents of the University of Texas System Β· Granted Feb 11, 2003 Β· Expires Feb 6, 2023

    expired
  24. US 6517855

    Method of sterilizing

    The Regents of the University of California Β· Granted Feb 11, 2003 Β· Expires Feb 6, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.